The United States is in the grip of a GLP-1 revolution. Over 44 million GLP-1 prescriptions were recorded across the United States in 2024, according to URBN Dental’s analysis of state-level usage data. But as drugs like Ozempic and Wegovy move from specialist treatment to everyday use, a quieter health issue is emerging in parallel. […]
The post